The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
MPN Advances Day 2019 | Challenges in myelofibrosis management
Andreas Reiter
• 15 Nov 2019
Andreas Reiter, MD, University Medical Centre, Mannheim, Germany, shares his opinion on the most significant challenges in myelofibrosis management, including cytopenia, splenomegaly and related symptoms. This interview took place at the Myeloproliferative Neoplasms Advances Day 2019 in London, UK.
